Gastrointestinal Motility Disorder Clinical Trial
Official title:
Intestinal Dysmotility in Patients With Functional Digestive Symptoms
Automatic and non-invasive diagnostic methods based on the analysis of internal (intraluminal) and external (abdominal) images have been recently developed to measure intestinal motility. In patients with severe motor disorders, such as intestinal pseudo-obstruction, these new non-invasive techniques have shown to be equivalent to conventional intestinal manometry, the current gold-standard. However, these new techniques also detect less obvious signs of intestinal motor dysfunction, which are not detectable by conventional manometry. High resolution manometry has been recently been applied to other parts of the digestive tract with great success, and probably will replace the actual gold-standard for intestinal motility evaluation. The investigators expect high-resolution manometry to be more sensitive than conventional manometry to the subtle motility disturbances detected by the new non-invasive techniques. The purpose of this project is to demonstrate that intestinal motor function can be measured more sensitively and accurately using a combination of new technologies: high resolution manometry and the non-invasive diagnostic methods based on the analysis of images. The combined use of these techniques, following a step-wise algorithm, could allow to determine the mechanism, the affected regions and severity of the dysfunction in patients with intestinal dysmotility.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04429802 -
The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity
|
N/A | |
| Completed |
NCT01644240 -
A Phase 1, Multiple Intravenous Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects
|
Phase 1 | |
| Withdrawn |
NCT04244877 -
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
|
Phase 3 | |
| Terminated |
NCT02573519 -
Gastrointestinal Motility Among Diabetes Patients
|
N/A | |
| Completed |
NCT03012594 -
Lanreotide in the Treatment of Small Bowel Motility Disorders
|
Phase 2 | |
| Not yet recruiting |
NCT05268328 -
The Effect of Foot Reflexology After Cesarean Section
|
||
| Completed |
NCT02245165 -
Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades
|
Phase 1 | |
| Completed |
NCT03552510 -
Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility
|
N/A | |
| Completed |
NCT01394055 -
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
|
Phase 1 | |
| Active, not recruiting |
NCT00793195 -
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
|
Phase 2 | |
| Recruiting |
NCT04208828 -
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
|
||
| Active, not recruiting |
NCT06347367 -
Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention
|
N/A | |
| Recruiting |
NCT05989763 -
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
|
N/A | |
| Recruiting |
NCT04988438 -
Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19
|
||
| Completed |
NCT01635608 -
Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water
|
Phase 1 |